The First-Line Treatment of Anaphylaxis Is to Have a Written Protocol

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCOLLETI JR., Jose
dc.contributor.authorCARVALHO, Werther Brunow de
dc.date.accessioned2018-03-06T15:18:50Z
dc.date.available2018-03-06T15:18:50Z
dc.date.issued2017
dc.description.indexMEDLINE
dc.identifier.citationPEDIATRIC CRITICAL CARE MEDICINE, v.18, n.11, p.1088-1089, 2017
dc.identifier.doi10.1097/PCC.0000000000001277
dc.identifier.eissn1947-3893
dc.identifier.issn1529-7535
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/25634
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartofPediatric Critical Care Medicine
dc.rightsrestrictedAccess
dc.rights.holderCopyright LIPPINCOTT WILLIAMS & WILKINS
dc.subject.otherepinephrine
dc.subject.othermanagement
dc.subject.wosCritical Care Medicine
dc.subject.wosPediatrics
dc.titleThe First-Line Treatment of Anaphylaxis Is to Have a Written Protocol
dc.typearticle
dc.type.categoryletter
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalCOLLETI JR., Jose:Hosp Santa Catarina, Pediat ICU, Sao Paulo, Brazil
hcfmusp.citation.scopus1
hcfmusp.contributor.author-fmusphcWERTHER BRUNOW DE CARVALHO
hcfmusp.description.beginpage1088
hcfmusp.description.endpage1089
hcfmusp.description.issue11
hcfmusp.description.volume18
hcfmusp.origemWOS
hcfmusp.origem.pubmed29099460
hcfmusp.origem.scopus2-s2.0-85066917924
hcfmusp.origem.wosWOS:000417100400035
hcfmusp.publisher.cityPHILADELPHIA
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceAbramowicz M, 2017, JAMA-J AM MED ASSOC, V317, P313, DOI 10.1001/jama.2016.14505
hcfmusp.relation.referenceBaalmann DV, 2016, AM J EMERG MED, V34, P174, DOI 10.1016/j.ajem.2015.10.003
hcfmusp.relation.referenceCalamelli E, 2014, INT J IMMUNOPATH PH, V27, P597, DOI 10.1177/039463201402700415
hcfmusp.relation.referenceChime NO, 2017, PEDIATR CRIT CARE ME, V18, P764, DOI 10.1097/PCC.0000000000001197
hcfmusp.relation.referenceColleti Junior J, 2016, J INTENSIVE CARE MED
hcfmusp.relation.referenceFarbman KS, 2017, PEDIATRICS
hcfmusp.relation.referenceSidhu N, 2016, PEDIATR EMERG CARE, V32, P508, DOI 10.1097/PEC.0000000000000864
hcfmusp.relation.referenceSimons FER, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-9
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication2baaab86-163c-4798-b170-4a2f0d798e52
relation.isAuthorOfPublication.latestForDiscovery2baaab86-163c-4798-b170-4a2f0d798e52
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_COLLETI JR._The_FirstLine_Treatment_of_Anaphylaxis_Is_to_Have_2017.PDF
Tamanho:
62.4 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - LIM/36